Literature DB >> 15716447

Cytoplasmic control of premature activation of a secreted protease zymogen: deletion of staphostatin B (SspC) in Staphylococcus aureus 8325-4 yields a profound pleiotropic phenotype.

Lindsey N Shaw1, Ewa Golonka, Grzegorz Szmyd, Simon J Foster, James Travis, Jan Potempa.   

Abstract

The cytoplasmic protein SspC of Staphylococcus aureus, referred to as staphostatin B, is a very specific, tightly binding inhibitor of the secreted protease staphopain B (SspB). SspC is hypothesized to protect intracellular proteins against proteolytic damage by prematurely folded and activated staphopain B (M. Rzychon, A. Sabat, K. Kosowska, J. Potempa, and A. Dubin, Mol. Microbiol. 49:1051-1066, 2003). Here we provide evidence that elimination of intracellular staphopain B activity is indeed the function of SspC. An isogenic sspC mutant of S. aureus 8325-4 exhibits a wide range of striking pleiotropic alterations in phenotype, which distinguish it from the parent. These changes include a defect in growth, a less structured peptidoglycan layer within the cell envelope, severely decreased autolytic activity, resistance to lysis by S. aureus phages, extensively diminished sensitivity to lysis by lysostaphin, the ability to form a biofilm, and a total lack of extracellular proteins secreted into the growth media. The same phenotype was also engineered by introduction of sspB into an 8325-4 sspBC mutant. In contrast, sspC inactivation in the SH1000 strain did not yield any significant changes in the mutant phenotype, apparently due to strongly reduced expression of sspB in the sigma B-positive background. The exact pathway by which these diverse aberrations are exerted in 8325-4 is unknown, but it is apparent that a very small amount of staphopain B (less than 20 ng per 200 microg of cell proteins) is sufficient to bring about these widespread changes. It is proposed that the effects observed are modulated through the proteolytic degradation of several cytoplasmic proteins within cells lacking the inhibitor. Seemingly, some of these proteins may play a role in protein secretion; hence, their proteolytic inactivation by SspB has pleiotropic effects on the SspC-deficient mutant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716447      PMCID: PMC1064019          DOI: 10.1128/JB.187.5.1751-1762.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  67 in total

1.  Mutation of sarA in Staphylococcus aureus limits biofilm formation.

Authors:  Karen E Beenken; Jon S Blevins; Mark S Smeltzer
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.

Authors:  J M Robinson; J K Hardman; G L Sloan
Journal:  J Bacteriol       Date:  1979-03       Impact factor: 3.490

4.  Role of metalloprotease in activation of the precursor of staphylococcal protease.

Authors:  G R Drapeau
Journal:  J Bacteriol       Date:  1978-11       Impact factor: 3.490

5.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

Review 6.  Defense against own arms: staphylococcal cysteine proteases and their inhibitors.

Authors:  Grzegorz Dubin
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

7.  Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases.

Authors:  C H Chung; H E Ives; S Almeda; A L Goldberg
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

8.  Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases.

Authors:  Malgorzata Rzychon; Artur Sabat; Klaudia Kosowska; Jan Potempa; Adam Dubin
Journal:  Mol Microbiol       Date:  2003-08       Impact factor: 3.501

9.  The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease.

Authors:  Renata Filipek; Malgorzata Rzychon; Aneta Oleksy; Milosz Gruca; Adam Dubin; Jan Potempa; Matthias Bochtler
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

10.  New shuttle vectors for Bacillus subtilis and Escherichia coli which allow rapid detection of inserted fragments.

Authors:  M A Sullivan; R E Yasbin; F E Young
Journal:  Gene       Date:  1984 Jul-Aug       Impact factor: 3.688

View more
  14 in total

1.  Investigations into sigmaB-modulated regulatory pathways governing extracellular virulence determinant production in Staphylococcus aureus.

Authors:  Lindsey N Shaw; Joanne Aish; Jessica E Davenport; Melanie C Brown; James K Lithgow; Kay Simmonite; Howard Crossley; James Travis; Jan Potempa; Simon J Foster
Journal:  J Bacteriol       Date:  2006-09       Impact factor: 3.490

2.  Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutant.

Authors:  Yang Song; Christopher S Lunde; Bret M Benton; Brian J Wilkinson
Journal:  Microb Drug Resist       Date:  2013-04-03       Impact factor: 3.431

3.  NsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus.

Authors:  Stacey L Kolar; Vijayaraj Nagarajan; Anna Oszmiana; Frances E Rivera; Halie K Miller; Jessica E Davenport; James T Riordan; Jan Potempa; David S Barber; Joanna Koziel; Mohamed O Elasri; Lindsey N Shaw
Journal:  Microbiology (Reading)       Date:  2011-05-12       Impact factor: 2.777

4.  The ω Subunit Governs RNA Polymerase Stability and Transcriptional Specificity in Staphylococcus aureus.

Authors:  Andy Weiss; Brittney D Moore; Miguel H J Tremblay; Dale Chaput; Astrid Kremer; Lindsey N Shaw
Journal:  J Bacteriol       Date:  2016-12-28       Impact factor: 3.490

5.  Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model.

Authors:  Assaf Raz; Anna Serrano; Maneesha Thaker; Tricia Alston; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  The dissemination of C10 cysteine protease genes in Bacteroides fragilis by mobile genetic elements.

Authors:  Roibeard F Thornton; Todd F Kagawa; Paul W O'Toole; Jakki C Cooney
Journal:  BMC Microbiol       Date:  2010-04-23       Impact factor: 3.605

7.  Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus.

Authors:  Lindsey N Shaw; Ing-Marie Jonsson; Vineet K Singh; Andrej Tarkowski; George C Stewart
Journal:  Infect Immun       Date:  2007-06-04       Impact factor: 3.441

Review 8.  A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase.

Authors:  Michael A Meehl; Jerome S Pinkner; Patricia J Anderson; Scott J Hultgren; Michael G Caparon
Journal:  PLoS Pathog       Date:  2005-12-02       Impact factor: 6.823

9.  Novel inhibitors of Staphylococcus aureus virulence gene expression and biofilm formation.

Authors:  Yibao Ma; Yuanxi Xu; Bryan D Yestrepsky; Roderick J Sorenson; Meng Chen; Scott D Larsen; Hongmin Sun
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  The effect of environmental conditions on expression of Bacteroides fragilis and Bacteroides thetaiotaomicron C10 protease genes.

Authors:  Roibeard F Thornton; Elizabeth C Murphy; Todd F Kagawa; Paul W O'Toole; Jakki C Cooney
Journal:  BMC Microbiol       Date:  2012-09-03       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.